Sign in
CompletedNo phase

Soluble Immune Checkpoints in Intra-Abdominal Infections

Key facts

Who runs it
Istanbul Training and Research Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
75 people enrolled
Started
1 Dec 2023
Ended
1 Aug 2025
Type of study
Observational, 3 groups
Treatments tested
  • Soluble Immune checkpoint levels
Record updated
8 July 2026

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients with intraabdominal infections due to gastrointestinal pathologies

Who cannot take part

  • Patients without intraabdominal infections
  • Malignities
  • Pregnancy
  • Immune deficiency

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Intraabdominal infections is a life-threatening syndrome with a high incidence and a significant economic burden. The early-stage cytokine storm and the late-stage immunosuppression contribute to the mortality of sepsis. Immune checkpoints expressed on lymphocytes and antigen-presenting cells (APCs) play a crucial role in the pathogenesis of sepsis by regulating immune dysfunction. Specific therapies targeting immune checkpoints have shown great potential in animal and preclinical studies, paving the way for further clinical research. In this study, the significance of serum immune checkpoints - sCD25 (IL-2Ra), 4-1BB, B7.2 (CD86), Free Active TGF-beta1, CTLA-4, PD-L1, PD-1, Tim-3, LAG-3, and Galectin-9 - will be investigated in patients with intraabdominal infection.

The 3 groups in the trial

  • Severe Intraabdominal Infection

    Severe Intraabdominal Infection patients with qSOFA 2 and 3

    Treatment: Soluble Immune checkpoint levels

  • Mild Intraabdominal Infection

    Mild Intraabdominal Infection patients with qSOFA 0 and 1

    Treatment: Soluble Immune checkpoint levels

  • Control

    Healthy Volunteers without intraabdominal infection

    Treatment: Soluble Immune checkpoint levels

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Serum Soluble Immune Checkpoint Molecules in Intra-abdominal Infection: Association With Disease Severity and Mortality
Record updated
8 July 2026